• Cleveland Clinic, a prestigious US healthcare institution, commences clinical use of CT:VQ™
• This is the third major US academic medical centre to adopt CT:VQ™ after Stanford and University of Miami
• The rapid adoption by elite institutions validates 4DMedical's commercialization strategy

4DMedical Limited (ASX:4DX), a global leader in respiratory imaging technology, has announced that Cleveland Clinic, one of the most prestigious healthcare institutions globally, has entered into a commercial arrangement for the clinical use of CT:VQ™. This agreement follows 4DMedical's proven commercialization model, providing an introductory pricing period to support clinical workflow integration, followed by full commercial terms. Cleveland Clinic's adoption of CT:VQ™ represents a major milestone in 4DMedical's strategy to establish CT:VQ™ as the standard of care at leading academic medical centres. As one of the most respected healthcare institutions in the United States, Cleveland Clinic's deployment will serve as a critical reference site, demonstrating CT:VQ™'s clinical utility and operational advantages to the broader U.S. hospital market. The commercial launch at Cleveland Clinic follows 4DMedical's recent successes at Stanford University and University of Miami, establishing a growing network of premier academic medical centres deploying CT:VQ™ for advanced respiratory diagnostics.